ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,0804
-0,12%
Bitcoin
69.483,17
0,22%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. abrdn Life Sciences Investors (HQL)

  7. abrdn Life Sciences Investors (HQL) News

HQL

abrdn Life Sciences Inve... (HQL)

abrdn Life Sciences Investors
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:HQL
DatumZeitQuelleÜberschriftSymbolFirma
05/06/202423h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
03/06/202423h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
03/06/202415h15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:HQLabrdn Life Sciences Investors
31/05/202421h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
29/05/202421h51Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NYSE:HQLabrdn Life Sciences Investors
24/05/202415h13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:HQLabrdn Life Sciences Investors
24/05/202401h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
17/05/202418h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
14/05/202419h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
10/05/202416h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
07/05/202423h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
29/02/202418h37Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NYSE:HQLabrdn Life Sciences Investors
07/02/202413h55Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:HQLabrdn Life Sciences Investors
12/01/202417h41Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:HQLabrdn Life Sciences Investors
04/01/202420h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
02/01/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
29/12/202313h54Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNYSE:HQLabrdn Life Sciences Investors
22/12/202320h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
22/12/202320h12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
12/12/202316h57Edgar (US Regulatory)Form N-CEN - Annual Report for Registered Investment CompaniesNYSE:HQLabrdn Life Sciences Investors
11/12/202322h11Edgar (US Regulatory)Form N-CSR - Certified Shareholder ReportNYSE:HQLabrdn Life Sciences Investors
15/11/202321h13Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NYSE:HQLabrdn Life Sciences Investors
06/11/202321h39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
06/11/202321h39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
06/11/202321h37Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
06/11/202321h36Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
06/11/202321h36Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
06/11/202321h35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
06/11/202321h34Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
06/11/202321h34Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
 Showing the most relevant articles for your search:NYSE:HQL

Kürzlich von Ihnen besucht

COIN
SOLUSD
Solana
USOTC
RHHBY
Roche (QX)
AMEX
SPY
SPDR S&P 500
DBI
TDXP
Tec DAX
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
NVDA
NVIDIA
DBI
SDXP
SDAX
NYSE
XOM
Exxon Mobil
CCOM
US100
US Tech 100
CCOM
US500
US 500
TG
ALV
Allianz
NASDAQ
AAPL
Apple
USOTC
BNPQY
BNP Paribas (QX)
DBI
MDAX
MDAX
TG
RHM
Rheinmetall
TG
BAYN
Bayer
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten